Anti-biofilm activity as a health issue

Frontiers in Microbiology

Volumn 7, Issue APR, 2016, Pages

  Miquel, Sylvie ^a   Lagrafeuille, Rosyne ^a   Souweine, Bertrand ^a,b   Forestier, Christiane ^a  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

Author keywords

Anti biofilm; Biofilm; Lock solution; Pathogens; Probiotics

Indexed keywords

CHLORHEXIDINE; MINOCYCLINE; RIFAMPICIN; SULFADIAZINE SILVER;

ANTI BIOFILM ACTIVITY; ANTIBIOTIC RESISTANCE; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIOPHAGE; BACTERIUM ADHERENCE; BIOFILM; CATHETER INFECTION; CENTRAL VENOUS CATHETER; MICROBIAL COMMUNITY; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NANOTECHNOLOGY; NONHUMAN; ORGANISMAL INTERACTION; PHOTODYNAMICS; PLANT PRODUCT; PLASMA GAS; PROTOZOON; PUBLIC HEALTH; QUORUM SENSING; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

EID: 84966425246     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2016.00592     Document Type: Review

References (162)

1. Abedi, D., Feizizadeh, S., Akbari, V., and Jafarian-Dehkordi, A. (2013). In vitro anti-bacterial and anti-adherence effects of Lactobacillus delbrueckii subsp bulgaricus on Escherichia coli. Res. Pharm. Sci. 8, 260-268
2. Abedon, S. T. (2015). Ecology of anti-biofilm agents ii: bacteriophage exploitation and biocontrol of Biofilm Bacteria. Pharm. Basel Switz. 8, 559-589. doi: 10.3390/ph8030559
3. Agharazii, M., Plamondon, I., Lebel, M., Douville, P., and Desmeules, S. (2005). Estimation of heparin leak into the systemic circulation after central venous catheter heparin lock. Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc. 20, 1238-1240. doi: 10.1093/ndt/gfh841
4. Allison, D. G., Cronin, M. A., Hawker, J., and Freeman, S. (2000). Influence of cranberry juice on attachment of Escherichia coli to glass. J. Basic Microbiol. 40, 3-6. doi: 10.1002/(SICI)1521-4028(200002)40:1<3::AID-JOBM3>3.0.CO;2-L
5. Ammons, M. C., and Copié, V. (2013). Mini-review: lactoferrin: a bioinspired, anti-biofilm therapeutic. Biofouling 29, 443-455. doi: 10.1080/08927014.2013.773317
6. Bach, A., Darby, D., Böttiger, B., Böhrer, H., Motsch, J., and Martin, E. (1996). Retention of the antibiotic teicoplanin on a hydromer-coated central venous catheter to prevent bacterial colonization in postoperative surgical patients. Intensive Care Med. 22, 1066-1069. doi: 10.1007/BF01699229
7. Bakkiyaraj, D., and Pandian, S. K. (2014). "Biofilm inhibition by nanoparticles, " in Antibiofilm Agents Springer Series on Biofilms, eds K. P. Rumbaugh and I. Ahmad (Berlin: Springer), 385-406. Available at: http://link.springer.com/chapter/10.1007/978-3-642-53833-9_17 [accessed September 23, 2015]
8. Barra, F., Roscetto, E., Soriano, A. A., Vollaro, A., Postiglione, I., Pierantoni, G. M., et al. (2015). Photodynamic and antibiotic therapy in combination to fight biofilms and resistant surface bacterial infections. Int. J. Mol. Sci. 16, 20417-20430. doi: 10.3390/ijms160920417
9. Benmechernene, Z., Fernandez-No, I., Kihal, M., Böhme, K., Calo-Mata, P., and Barros-Velazquez, J. (2013). Recent patents on bacteriocins: food and biomedical applications. Recent Pat. DNA Gene Seq. 7, 66-73. doi: 10.2174/1872215611307010010
10. Berra, L., Kolobow, T., Laquerriere, P., Pitts, B., Bramati, S., Pohlmann, J., et al. (2008). Internally coated endotracheal tubes with silver sulfadiazine in polyurethane to prevent bacterial colonization: a clinical trial. Intensive Care Med. 34, 1030-1037. doi: 10.1007/s00134-008-1100-1
11. Betjes, M. G. H., and van Agteren, M. (2004). Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution. Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc. 19, 1546-1551. doi: 10.1093/ndt/gfh014
12. Beyth, N., Houri-Haddad, Y., Domb, A., Khan, W., Hazan, R., Beyth, N., et al. (2015). Alternative antimicrobial approach: nano-antimicrobial materials, alternative antimicrobial approach: nano-antimicrobial materials. evid.-based complement. altern. med. evid.-based complement. Altern. Med. 2015:e246012. doi: 10.1155/2015/246012
13. Bisseling, T. M., Willems, M. C., Versleijen, M. W., Hendriks, J. C., Vissers, R. K., and Wanten, G. J. (2010). Taurolidine lock is highly effective in preventing catheter-related bloodstream infections in patients on home parenteral nutrition: a heparin-controlled prospective trial. Clin. Nutr. Edinb. Scotl. 29, 464-468. doi: 10.1016/j.clnu.2009.12.005
14. Bonne, S., Mazuski, J. E., Sona, C., Schallom, M., Boyle, W., Buchman, T. G., et al. (2015). Effectiveness of minocycline and rifampin vs chlorhexidine and silver sulfadiazine-impregnated central venous catheters in preventing central line-associated bloodstream infection in a high-volume academic intensive care unit: a before and after trial. J. Am. Coll. Surg. 221, 739-747. doi: 10.1016/j.jamcollsurg.2015.05.013
15. Brackman, G., and Coenye, T. (2015). Quorum sensing inhibitors as anti-biofilm agents. Curr. Pharm. Des. 21, 5-11. doi: 10.2174/1381612820666140905114627
16. Broom, J. K., Krishnasamy, R., Hawley, C. M., Playford, E. G., and Johnson, D. W. (2012). A randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of catheter associated infection in haemodialysis patients-the HEALTHY-CATH trial. BMC Nephrol. 13:146. doi: 10.1186/1471-2369-13-146
17. Brown, H. L., Hanman, K., Reuter, M., Betts, R. P., and van Vliet, A. H. M. (2015). Campylobacter jejuni biofilms contain extracellular DNA and are sensitive to DNase I treatment. Front. Microbiol. 6:699. doi: 10.3389/fmicb.2015.00699
18. Bryers, J. D. (2008). Medical biofilms. Biotechnol. Bioeng. 100, 1-18. doi: 10.1002/bit.21838
19. Caballero-Franco, C., Keller, K., De Simone, C., and Chadee, K. (2007). The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 292, G315-G322. doi: 10.1152/ajpgi.00265.2006
20. Cai, T., Caola, I., Tessarolo, F., Piccoli, F., D'Elia, C., Caciagli, P., et al. (2014). Solidago, orthosiphon, birch and cranberry extracts can decrease microbial colonization and biofilm development in indwelling urinary catheter: a microbiologic and ultrastructural pilot study. World J. Urol. 32, 1007-1014. doi: 10.1007/s00345-013-1173-5
21. Castro, J., Henriques, A., Machado, A., Henriques, M., Jefferson, K. K., and Cerca, N. (2013). Reciprocal interference between Lactobacillus spp. and Gardnerella vaginalis on initial adherence to epithelial cells. Int. J. Med. Sci. 10, 1193-1198. doi: 10.7150/ijms.6304
22. Cha, J.-O., Park, Y.-K., Lee, Y. S., and Chung, G. T. (2011). In vitro biofilm formation and bactericidal activities of methicillin-resistant Staphylococcus aureus clones prevalent in Korea. Diagn. Microbiol. Infect. Dis. 70, 112-118. doi: 10.1016/j.diagmicrobio.2010.11.018
23. Chambless, J. D., Hunt, S. M., and Stewart, P. S. (2006). A three-dimensional computer model of four hypothetical mechanisms protecting biofilms from antimicrobials. Appl. Environ. Microbiol. 72, 2005-2013. doi: 10.1128/AEM.72.3.2005-2013.2006
24. Chew, S. Y., Cheah, Y. K., Seow, H. F., Sandai, D., and Than, L. T. L. (2015). In vitro modulation of probiotic bacteria on the biofilm of Candida glabrata. Anaerobe 34, 132-138. doi: 10.1016/j.anaerobe.2015.05.009
25. Chopra, L., Singh, G., Kumar Jena, K., and Sahoo, D. K. (2015). Sonorensin: a new bacteriocin with potential of an anti-biofilm agent and a food biopreservative. Sci. Rep. 5, 13412. doi: 10.1038/srep13412
26. Christopher, A. B., Arndt, A., Cugini, C., and Davey, M. E. (2010). A streptococcal effector protein that inhibits Porphyromonas gingivalis biofilm development. Microbiol. Read. Engl. 156, 3469-3477. doi: 10.1099/mic.0.042671-0
27. Cirioni, O., Mocchegiani, F., Ghiselli, R., Silvestri, C., Gabrielli, E., Marchionni, E., et al. (2010). Daptomycin and rifampin alone and in combination prevent vascular graft biofilm formation and emergence of antibiotic resistance in a subcutaneous rat pouch model of staphylococcal infection. Eur. J. Vasc. Endovasc. Surg. Off. J. Eur. Soc. Vasc. Surg. 40, 817-822. doi: 10.1016/j.ejvs.2010.08.009
28. Claret, L., Miquel, S., Vieille, N., Ryjenkov, D. A., Gomelsky, M., and Darfeuille-Michaud, A. (2007). The flagellar sigma factor FliA regulates adhesion and invasion of Crohn disease-associated Escherichia coli via a cyclic dimeric GMP-dependent pathway. J. Biol. Chem. 282, 33275-33283. doi: 10.1074/jbc.M702800200
29. Costerton, J. W., Stewart, P. S., and Greenberg, E. P. (1999). Bacterial biofilms: a common cause of persistent infections. Science 284, 1318-1322. doi: 10.1126/science.284.5418.1318
30. Darouiche, R. O., Berger, D. H., Khardori, N., Robertson, C. S., Wall, M. J., Metzler, M. H., et al. (2005). Comparison of antimicrobial impregnation with tunneling of long-term central venous catheters. Ann. Surg. 242, 193-200. doi: 10.1097/01.sla.0000171874.29934.61
31. Das, J. K., Mishra, D., Ray, P., Tripathy, P., Beuria, T. K., Singh, N., et al. (2013). In vitro evaluation of anti-infective activity of a Lactobacillus plantarum strain against Salmonella enterica serovar Enteritidis. Gut Pathog. 5:11. doi: 10.1186/1757-4749-5-11
32. Davies, D. G., and Marques, C. N. H. (2009). A fatty acid messenger is responsible for inducing dispersion in microbial biofilms. J. Bacteriol. 191, 1393-1403. doi: 10.1128/JB.01214-08
33. Dawgul, M., Maciejewska, M., Jaskiewicz, M., Karafova, A., and Kamysz, W. (2014). Antimicrobial peptides as potential tool to fight bacterial biofilm. Acta Pol. Pharm. 71, 39-47
34. de la Fuente-Núñez, C., Reffuveille, F., Mansour, S., and Hancock, R. E. W. (2014). A broad-spectrum antibiofilm peptide enhances antibiotic action against bacterial biofilms. Antimicrob. Agents Chemother. 58, 5363-5371. doi: 10.1128/AAC.03163-14
35. Desrousseaux, C., Sautou, V., Descamps, S., and Traoré, O. (2013). Modification of the surfaces of medical devices to prevent microbial adhesion and biofilm formation. J. Hosp. Infect. 85, 87-93. doi: 10.1016/j.jhin.2013.06.015
36. Dixon, J. J., Steele, M., and Makanjuola, A. D. (2012). Anti-microbial locks increase the prevalence of Staphylococcus aureus and antibiotic-resistant Enterobacter: observational retrospective cohort study. Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc. 27, 3575-3581. doi: 10.1093/ndt/gfs081
37. Dogra, G. K., Herson, H., Hutchison, B., Irish, A. B., Heath, C. H., Golledge, C., et al. (2002). Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study. J. Am. Soc. Nephrol. 13, 2133-2139. doi: 10.1097/01.ASN.0000022890.29656.22
38. Donlan, R. M., and Costerton, J. W. (2002). Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15, 167-193. doi: 10.1128/CMR.15.2.167-193.2002
39. Doroshenko, N., Tseng, B. S., Howlin, R. P., Deacon, J., Wharton, J. A., Thurner, P. J., et al. (2014). Extracellular DNA impedes the transport of vancomycin in Staphylococcus epidermidis biofilms preexposed to subinhibitory concentrations of vancomycin. Antimicrob. Agents Chemother. 58, 7273-7282. doi: 10.1128/AAC.03132-14
40. Dörr, T., Vulic, M., and Lewis, K. (2010). Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. PLoS Biol. 8:e1000317. doi: 10.1371/journal.pbio.1000317
41. Droste, J. C., Jeraj, H. A., MacDonald, A., and Farrington, K. (2003). Stability and in vitro efficacy of antibiotic-heparin lock solutions potentially useful for treatment of central venous catheter-related sepsis. J. Antimicrob. Chemother. 51, 849-855. doi: 10.1093/jac/dkg179
42. Dümichen, M. J., Seeger, K., Lode, H. N., Kühl, J. S., Ebell, W., Degenhardt, P., et al. (2012). Randomized controlled trial of taurolidine citrate versus heparin as catheter lock solution in paediatric patients with haematological malignancies. J. Hosp. Infect. 80, 304-309. doi: 10.1016/j.jhin.2012.01.003
43. Ermolaeva, S. A., Sysolyatina, E. V., and Gintsburg, A. L. (2015). Atmospheric pressure nonthermal plasmas for bacterial biofilm prevention and eradication. Biointerphases 10, 029404. doi: 10.1116/1.4914382
44. Fukuda, S., Toh, H., Taylor, T. D., Ohno, H., and Hattori, M. (2012). Acetate-producing bifidobacteria protect the host from enteropathogenic infection via carbohydrate transporters. Gut Microbes 3, 449-454. doi: 10.4161/gmic.21214
45. Gawande, P. V., Leung, K. P., and Madhyastha, S. (2014). Antibiofilm and antimicrobial efficacy of dispersinb®-KSL-W peptide-based wound gel against chronic wound infection associated bacteria. Curr. Microbiol. 68, 635-641. doi: 10.1007/s00284-014-0519-6
46. Ghorbanzadeh, R., Pourakbari, B., and Bahador, A. (2015). Effects of baseplates of orthodontic appliances with in situ generated silver nanoparticles on cariogenic bacteria: a randomized, double-blind cross-over clinical trial. J. Contemp. Dent. Pract. 16, 291-298. doi: 10.5005/jp-journals-10024-1678
47. Girardot, M., Guerineau, A., Boudesocque, L., Costa, D., Bazinet, L., Enguehard-Gueiffier, C., et al. (2014). Promising results of cranberry in the prevention of oral Candida biofilms. Pathog. Dis. 70, 432-439. doi: 10.1111/2049-632X.12168
48. Goncalves, M. D. S., Delattre, C., Balestrino, D., Charbonnel, N., Elboutachfaiti, R., Wadouachi, A., et al. (2014). Anti-biofilm activity: a function of Klebsiella pneumoniae capsular polysaccharide. PLoS ONE 9:e99995. doi: 10.1371/journal.pone.0099995
49. Günther, F., Wabnitz, G. H., Stroh, P., Prior, B., Obst, U., Samstag, Y., et al. (2009). Host defence against Staphylococcus aureus biofilms infection: phagocytosis of biofilms by polymorphonuclear neutrophils (PMN). Mol. Immunol. 46, 1805-1813. doi: 10.1016/j.molimm.2009.01.020
50. Hall-Stoodley, L., and Stoodley, P. (2009). Evolving concepts in biofilm infections. Cell. Microbiol. 11, 1034-1043. doi: 10.1111/j.1462-5822.2009.01323.x
51. Hamblin, M. R., and Hasan, T. (2004). Photodynamic therapy: a new antimicrobial approach to infectious disease? Photochem. Photobiol. Sci. Off. J. Eur. Photochem. Assoc. Eur. Soc. Photobiol. 3, 436-450. doi: 10.1039/b311900a
52. Handrup, M. M., Møller, J. K., and Schrøder, H. (2013). Central venous catheters and catheter locks in children with cancer: a prospective randomized trial of taurolidine versus heparin. Pediatr. Blood Cancer 60, 1292-1298. doi: 10.1002/pbc.24482
53. He, X., McLean, J. S., Guo, L., Lux, R., and Shi, W. (2014). The social structure of microbial community involved in colonization resistance. ISME J. 8, 564-574. doi: 10.1038/ismej.2013.172
54. He, X., Tian, Y., Guo, L., Lux, R., Zusman, D. R., and Shi, W. (2010). Oral-derived bacterial flora defends its domain by recognizing and killing intruders-a molecular analysis using Escherichia coli as a model intestinal bacterium. Microb. Ecol. 60, 655-664. doi: 10.1007/s00248-010-9708-4
55. Hengzhuang, W., Wu, H., Ciofu, O., Song, Z., and Høiby, N. (2012). In vivo pharmacokinetics/pharmacodynamics of colistin and imipenem in Pseudomonas aeruginosa biofilm infection. Antimicrob. Agents Chemother. 56, 2683-2690. doi: 10.1128/AAC.06486-11
56. Hill, C., Guarner, F., Reid, G., Gibson, G. R., Merenstein, D. J., Pot, B., et al. (2014). Expert consensus document. The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 11, 506-514. doi: 10.1038/nrgastro.2014.66
57. Hockenhull, J. C., Dwan, K. M., Smith, G. W., Gamble, C. L., Boland, A., Walley, T. J., et al. (2009). The clinical effectiveness of central venous catheters treated with anti-infective agents in preventing catheter-related bloodstream infections: a systematic review. Crit. Care Med. 37, 702-712. doi: 10.1097/CCM.0b013e3181958915
58. Hsu, C.-Y., Lin, M.-H., Chen, C.-C., Chien, S.-C., Cheng, Y.-H., Su, I.-N., et al. (2011). Vancomycin promotes the bacterial autolysis, release of extracellular DNA, and biofilm formation in vancomycin-non-susceptible Staphylococcus aureus. FEMS Immunol. Med. Microbiol. 63, 236-247. doi: 10.1111/j.1574-695X.2011.00846.x
59. Husain, F. M., Ahmad, I., Khan, M. S., and Al-Shabib, N. A. (2015). Trigonella foenum-graceum (Seed) extract interferes with quorum sensing regulated traits and biofilm formation in the strains of Pseudomonas aeruginosa and Aeromonas hydrophila. Evid. Based Complement. Altern. Med. 2015, 879540. doi: 10.1155/2015/879540
60. Huws, S. A., McBain, A. J., and Gilbert, P. (2005). Protozoan grazing and its impact upon population dynamics in biofilm communities. J. Appl. Microbiol. 98, 238-244. doi: 10.1111/j.1365-2672.2004.02449.x
61. Irie, Y., O'Toole, G. A., and Yuk, M. H. (2005). Pseudomonas aeruginosa rhamnolipids disperse Bordetella bronchiseptica biofilms. FEMS Microbiol. Lett. 250, 237-243. doi: 10.1016/j.femsle.2005.07.012
62. Iwase, T., Uehara, Y., Shinji, H., Tajima, A., Seo, H., Takada, K., et al. (2010). Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization. Nature 465, 346-349. doi: 10.1038/nature09074
63. Jakobsen, T. H., van Gennip, M., Phipps, R. K., Shanmugham, M. S., Christensen, L. D., Alhede, M., et al. (2012). Ajoene, a sulfur-rich molecule from garlic, inhibits genes controlled by quorum sensing. Antimicrob. Agents Chemother. 56, 2314-2325. doi: 10.1128/AAC.05919-11
64. Jankowska, A., Laubitz, D., Antushevich, H., Zabielski, R., and Grzesiuk, E. (2008). Competition of Lactobacillus paracasei with Salmonella enterica for Adhesion to Caco-2 Cells. J. Biomed. Biotechnol. 2008:357964. doi: 10.1155/2008/357964
65. Justo, J. A., and Bookstaver, P. B. (2014). Antibiotic lock therapy: review of technique and logistical challenges. Infect. Drug Resist. 7, 343-363. doi: 10.2147/IDR.S51388
66. Kalfon, P., de Vaumas, C., Samba, D., Boulet, E., Lefrant, J.-Y., Eyraud, D., et al. (2007). Comparison of silver-impregnated with standard multi-lumen central venous catheters in critically ill patients. Crit. Care Med. 35, 1032-1039. doi: 10.1097/01.CCM.0000259378.53166.1B
67. Kanaa, M., Wright, M. J., Akbani, H., Laboi, P., Bhandari, S., and Sandoe, J. A. T. (2015). Cathasept line lock and microbial colonization of tunneled hemodialysis catheters: a multicenter randomized controlled trial. Am. J. Kidney Dis. Off. J. Natl. Kidney Found. 66, 1015-1023. doi: 10.1053/j.ajkd.2015.04.047
68. Kaplan, J. B. (2009). Therapeutic potential of biofilm-dispersing enzymes. Int. J. Artif. Organs. 32, 545-554
69. Kaplan, J. B., Izano, E. A., Gopal, P., Karwacki, M. T., Kim, S., Bose, J. L., et al. (2012). Low levels of ß-lactam antibiotics induce extracellular DNA release and biofilm formation in Staphylococcus aureus. mBio 3:e198. doi: 10.1128/mBio.00198-12
70. Kaplan, J. B., Ragunath, C., Velliyagounder, K., Fine, D. H., and Ramasubbu, N. (2004). Enzymatic detachment of Staphylococcus epidermidis biofilms. Antimicrob. Agents Chemother. 48, 2633-2636. doi: 10.1128/AAC.48.7.2633-2636.2004
71. Karwacki, M. T., Kadouri, D. E., Bendaoud, M., Izano, E. A., Sampathkumar, V., Inzana, T. J., et al. (2013). Antibiofilm activity of Actinobacillus pleuropneumoniae serotype 5 capsular polysaccharide. PLoS ONE 8:e63844. doi: 10.1371/journal.pone.0063844
72. Khan, M. S. A., Ahmad, I., Sajid, M., and Cameotra, S. S. (2014). "Current and emergent control strategies for medical biofilms, " in Antibiofilm Agents Springer Series on Biofilms, eds K. P. Rumbaugh and I. Ahmad (Berlin: Springer), 117-159. Available at: http://link.springer.com/chapter/10.1007/978-3-642-53833-9_7 [accessed September 18, 2015]
73. Kim, Y., Oh, S., and Kim, S. H. (2009). Released exopolysaccharide (r-EPS) produced from probiotic bacteria reduce biofilm formation of enterohemorrhagic Escherichia coli O157:H7. Biochem. Biophys. Res. Commun. 379, 324-329. doi: 10.1016/j.bbrc.2008.12.053
74. Kollef, M. H., Afessa, B., Anzueto, A., Veremakis, C., Kerr, K. M., Margolis, B. D., et al. (2008). Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial. JAMA 300, 805-813. doi: 10.1001/jama.300.7.805
75. Kwan, B. W., Valenta, J. A., Benedik, M. J., and Wood, T. K. (2013). Arrested protein synthesis increases persister-like cell formation. Antimicrob. Agents Chemother. 57, 1468-1473. doi: 10.1128/AAC.02135-12
76. Lai, N. M., Chaiyakunapruk, N., Lai, N. A., O'Riordan, E., Pau, W. S. C., and Saint, S. (2013). Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults. Cochrane Database Syst. Rev. 6:CD007878. doi: 10.1002/14651858.CD007878.pub2
77. Landini, G., Riccobono, E., Giani, T., Arena, F., Rossolini, G. M., and Pallecchi, L. (2015). Bactericidal activity of ceftaroline against mature Staphylococcus aureus biofilms. Int. J. Antimicrob. Agents 45, 551-553. doi: 10.1016/j.ijantimicag.2015.01.001
78. Landry, D. L., Braden, G. L., Gobeille, S. L., Haessler, S. D., Vaidya, C. K., and Sweet, S. J. (2010). Emergence of gentamicin-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis. Clin. J. Am. Soc. Nephrol. 5, 1799-1804. doi: 10.2215/CJN.01270210
79. LaPlante, K. L., and Woodmansee, S. (2009). Activities of daptomycin and vancomycin alone and in combination with rifampin and gentamicin against biofilm-forming methicillin-resistant Staphylococcus aureus isolates in an experimental model of endocarditis. Antimicrob. Agents Chemother. 53, 3880-3886. doi: 10.1128/AAC.00134-09
80. Lardon, L. A., Merkey, B. V., Martins, S., Dötsch, A., Picioreanu, C., Kreft, J.-U., et al. (2011). iDynoMiCS: next-generation individual-based modelling of biofilms. Environ. Microbiol. 13, 2416-2434. doi: 10.1111/j.1462-2920.2011.02414.x
81. Lázaro-Díez, M., Remuzgo-Martínez, S., Rodríguez-Mirones, C., Acosta, F., Icardo, J. M., Martínez-Martínez, L., et al. (2016). Effects of subinhibitory concentrations of ceftaroline on methicillin-resistant Staphylococcus aureus (MRSA) biofilms. PLoS ONE 11:e0147569. doi: 10.1371/journal.pone.0147569
82. Lebeaux, D., Ghigo, J.-M., and Beloin, C. (2014). Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics. Microbiol. Mol. Biol. Rev. 78, 510-543. doi: 10.1128/MMBR.00013-14
83. León, C., Ruiz-Santana, S., Rello, J., de la Torre, M. V., Vallés, J., Alvarez-Lerma, F., et al. (2004). Benefits of minocycline and rifampin-impregnated central venous catheters. A prospective, randomized, double-blind, controlled, multicenter trial. Intensive Care Med. 30, 1891-1899. doi: 10.1007/s00134-004-2378-2
84. Leoni, L., and Landini, P. (2014). Microbiological methods for target-oriented screening of biofilm inhibitors. Methods Mol. Biol. 1147, 175-186. doi: 10.1007/978-1-4939-0467-9_12
85. Lin, X., Chen, X., Chen, Y., Jiang, W., and Chen, H. (2015). The effect of five probiotic lactobacilli strains on the growth and biofilm formation of Streptococcus mutans. Oral. Dis. 21, e128-e134. doi: 10.1111/odi.12257
86. Lindsay, D., and von Holy, A. (2006). Bacterial biofilms within the clinical setting: what healthcare professionals should know. J. Hosp. Infect. 64, 313-325. doi: 10.1016/j.jhin.2006.06.028
87. Liu, H., Liu, H., Deng, J., Chen, L., Yuan, L., and Wu, Y. (2014). Preventing catheter-related bacteremia with taurolidine-citrate catheter locks: a systematic review and meta-analysis. Blood Purif. 37, 179-187. doi: 10.1159/000360271
88. Liu, P.-F., Shi, W., Zhu, W., Smith, J. W., Hsieh, S.-L., Gallo, R. L., et al. (2010). Vaccination targeting surface FomA of Fusobacterium nucleatum against bacterial co-aggregation: implication for treatment of periodontal infection and halitosis. Vaccine 28, 3496-3505. doi: 10.1016/j.vaccine.2010.02.047
89. Lorente, L., Lecuona, M., Jiménez, A., Raja, L., Cabrera, J., Gonzalez, O., et al. (2015). Chlorhexidine-silver sulfadiazine-or rifampicin-miconazole-impregnated venous catheters decrease the risk of catheter-related bloodstream infection similarly. Am. J. Infect. Control 44, 50-53. doi: 10.1016/j.ajic.2015.08.014
90. Macfarlane, S., and Dillon, J. F. (2007). Microbial biofilms in the human gastrointestinal tract. J. Appl. Microbiol. 102, 1187-1196. doi: 10.1111/j.1365-2672.2007.03287.x
91. Maki, D. G., Ash, S. R., Winger, R. K., Lavin, P., and Investigators. (2011). A novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: a multi-center, controlled, randomized trial. Crit. Care Med. 39, 613-620. doi: 10.1097/CCM.0b013e318206b5a2
92. Maki, D. G., Kluger, D. M., and Crnich, C. J. (2006). The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin. Proc. 81, 1159-1171. doi: 10.4065/81.9.1159
93. Marquès, C., Laurent, F., Forestier, C., Pracros, A., Tasse, J., Collin, V., et al. (2015). Effects of antibiotics on biofilm and unattached cells of a clinical Staphylococcus aureus isolate from bone and joint infection. J. Med. Microbiol. 64, 1021-1026. doi: 10.1099/jmm.0.000125
94. Martín, R., Miquel, S., Langella, P., and Bermúdez-Humarán, L. G. (2014a). The role of metagenomics in understanding the human microbiome in health and disease. Virulence 5, 413-423. doi: 10.4161/viru.27864
95. Martín, R., Miquel, S., Ulmer, J., Langella, P., and Bermúdez-Humarán, L. G. (2014b). Gut ecosystem: how microbes help us. Benef. Microbes 5, 219-233. doi: 10.3920/BM2013.0057
96. Mascio, C. T. M., Alder, J. D., and Silverman, J. A. (2007). Bactericidal action of daptomycin against stationary-phase and nondividing Staphylococcus aureus cells. Antimicrob. Agents Chemother. 51, 4255-4260. doi: 10.1128/AAC.00824-07
97. Mermel, L. A., and Alang, N. (2014). Adverse effects associated with ethanol catheter lock solutions: a systematic review. J. Antimicrob. Chemother. 69, 2611-2619. doi: 10.1093/jac/dku182
98. Mermel, L. A., Allon, M., Bouza, E., Craven, D. E., Flynn, P., O'Grady, N. P., et al. (2009). Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 49, 1-45. doi: 10.1086/599376
99. Miquel, S., Beaumont, M., Martín, R., Langella, P., Braesco, V., and Thomas, M. (2015). A proposed framework for an appropriate evaluation scheme for microorganisms as novel foods with a health claim in Europe. Microb. Cell Factories 14:48. doi: 10.1186/s12934-015-0229-1
100. Morán, A., Gutiérrez, S., Martínez-Blanco, H., Ferrero, M. A., Monteagudo-Mera, A., and Rodríguez-Aparicio, L. B. (2014). Non-toxic plant metabolites regulate Staphylococcus viability and biofilm formation: a natural therapeutic strategy useful in the treatment and prevention of skin infections. Biofouling 30, 1175-1182. doi: 10.1080/08927014.2014.976207
101. Neethirajan, S., Clond, M. A., and Vogt, A. (2014). Medical biofilms-nanotechnology approaches. J. Biomed. Nanotechnol. 10, 2806-2827. doi: 10.1166/jbn.2014.1892
102. Ng, M., Epstein, S. B., Callahan, M. T., Piotrowski, B. O., Simon, G. L., Roberts, A. D., et al. (2014). Induction of MRSA biofilm by low-dose ß-lactam antibiotics: specificity, prevalence and dose-response effects. Dose Res. Publ. Int. Hormesis Soc. 12, 152-161. doi: 10.2203/dose-response.13-021.Kaplan
103. Nitschke, M., Araújo, L. V., Costa, S. G., Pires, R. C., Zeraik, A. E., Fernandes, A. C. L. B., et al. (2009). Surfactin reduces the adhesion of food-borne pathogenic bacteria to solid surfaces. Lett. Appl. Microbiol. 49, 241-247. doi: 10.1111/j.1472-765X.2009.02646.x
104. Nouaille, S., Rault, L., Jeanson, S., Loubière, P., Le Loir, Y., and Even, S. (2014). Contribution of Lactococcus lactis reducing properties to the downregulation of a major virulence regulator in Staphylococcus aureus, the agr system. Appl. Environ. Microbiol. 80, 7028-7035. doi: 10.1128/AEM.02287-14
105. Okuda, K., Zendo, T., Sugimoto, S., Iwase, T., Tajima, A., Yamada, S., et al. (2013). Effects of bacteriocins on methicillin-resistant Staphylococcus aureus biofilm. Antimicrob. Agents Chemother. 57, 5572-5579. doi: 10.1128/AAC.00888-13
106. Olson, M. E., Slater, S. R., Rupp, M. E., and Fey, P. D. (2010). Rifampicin enhances activity of daptomycin and vancomycin against both a polysaccharide intercellular adhesin (PIA)-dependent and-independent Staphylococcus epidermidis biofilm. J. Antimicrob. Chemother. 65, 2164-2171. doi: 10.1093/jac/dkq314
107. Örmälä, A.-M., and Jalasvuori, M. (2013). Phage therapy. Bacteriophage 3:e24219. doi: 10.4161/bact.24219
108. Pasquaroli, S., Citterio, B., Cesare, A. D., Amiri, M., Manti, A., Vuotto, C., et al. (2014). Role of daptomycin in the induction and persistence of the viable but non-culturable state of Staphylococcus aureus biofilms. Pathog. Basel Switz. 3, 759-768. doi: 10.3390/pathogens3030759
109. Pérez-Granda, M. J., Barrio, J. M., Muñoz, P., Hortal, J., Rincón, C., Rabadán, P. M., et al. (2014). Ethanol lock therapy (E-Lock) in the prevention of catheter-related bloodstream infections (CR-BSI) after major heart surgery (MHS): a randomized clinical trial. PLoS ONE 9:e91838. doi: 10.1371/journal.pone.0091838
110. Phillips, K. S., Patwardhan, D., and Jayan, G. (2015). Biofilms, medical devices, and antibiofilm technology: key messages from a recent public workshop. Am. J. Infect. Control 43, 2-3. doi: 10.1016/j.ajic.2014.09.019
111. Picioreanu, C., Kreft, J.-U., and Van Loosdrecht, M. C. M. (2004). Particle-based multidimensional multispecies biofilm model. Appl. Environ. Microbiol. 70, 3024-3040. doi: 10.1128/AEM.70.5.3024-3040.2004
112. Prince, T., McBain, A. J., and O'Neill, C. A. (2012). Lactobacillus reuteri protects epidermal keratinocytes from Staphylococcus aureus-induced cell death by competitive exclusion. Appl. Environ. Microbiol. 78, 5119-5126. doi: 10.1128/AEM.00595-12
113. Quinn, G. A., Maloy, A. P., Banat, M. M., and Banat, I. M. (2013). A comparison of effects of broad-spectrum antibiotics and biosurfactants on established bacterial biofilms. Curr. Microbiol. 67, 614-623. doi: 10.1007/s00284-013-0412-8
114. Quintas, V., Prada-López, I., Donos, N., Suárez-Quintanilla, D., and Tomás, I. (2015). Antiplaque effect of essential oils and 0.2% chlorhexidine on an in situ model of oral biofilm growth: a randomised clinical trial. PLoS ONE 10:e0117177. doi: 10.1371/journal.pone.0117177
115. Rafsanjany, N., Sendker, J., Brand, S., Doubrindt, U., and Hensel, A. (2015). In vivo consumption of cranberry exerts ex vivo antiadhesive activity against FimH-dominated uropathogenic E. coli: a combined in vivo, ex vivo, and in vitro study of an extract from Vaccinium macrocarpon. J. Agric. Food Chem. 63, 8804-8818. doi: 10.1021/acs.jafc.5b03030
116. Rahmani-Badi, A., Sepehr, S., Mohammadi, P., Soudi, M. R., Babaie-Naiej, H., and Fallahi, H. (2014). A combination of cis-2-decenoic acid and antibiotics eradicates pre-established catheter-associated biofilms. J. Med. Microbiol. 63, 1509-1516. doi: 10.1099/jmm.0.075374-0
117. RAISIN (2015). Available at: http://www.invs.sante.fr/Publications-et-outils/Rapports-et-syntheses/Maladies-infectieuses/2015/Enquete-nationale-de-prevalence-des-infections-nosocomiales-et-des-traitements-anti-infectieux-en-etablissements-d-hospitalisation-a-domicile-HAD-France-mai-juin-2012 [accessed December 21, 2015]
118. Ramos, E. R., Reitzel, R., Jiang, Y., Hachem, R. Y., Chaftari, A. M., Chemaly, R. F., et al. (2011). Clinical effectiveness and risk of emerging resistance associated with prolonged use of antibiotic-impregnated catheters: more than 0.5 million catheter days and 7 years of clinical experience. Crit. Care Med. 39, 245-251. doi: 10.1097/CCM.0b013e3181feb83e
119. Rasko, D. A., and Sperandio, V. (2010). Anti-virulence strategies to combat bacteria-mediated disease. Nat. Rev. Drug Discov. 9, 117-128. doi: 10.1038/nrd3013
120. Ren, D., Li, C., Qin, Y., Yin, R., Li, X., Tian, M., et al. (2012). Inhibition of Staphylococcus aureus adherence to Caco-2 cells by lactobacilli and cell surface properties that influence attachment. Anaerobe 18, 508-515. doi: 10.1016/j.anaerobe.2012.08.001
121. Rendueles, O., Beloin, C., Latour-Lambert, P., and Ghigo, J.-M. (2014). A new biofilm-associated colicin with increased efficiency against biofilm bacteria. ISME J. 8, 1275-1288. doi: 10.1038/ismej.2013.238
122. Rendueles, O., and Ghigo, J.-M. (2012). Multi-species biofilms: how to avoid unfriendly neighbors. FEMS Microbiol. Rev. 36, 972-989. doi: 10.1111/j.1574-6976.2012.00328.x
123. Rendueles, O., and Ghigo, J.-M. (2015). Mechanisms of competition in biofilm communities. Microbiol. Spectr. 3, 1-18. doi: 10.1128/microbiolspec.MB-0009-2014
124. Rieu, A., Aoudia, N., Jego, G., Chluba, J., Yousfi, N., Briandet, R., et al. (2014). The biofilm mode of life boosts the anti-inflammatory properties of Lactobacillus. Cell. Microbiol. 16, 1836-1853. doi: 10.1111/cmi.12331
125. Rossmann, F. S., Racek, T., Wobser, D., Puchalka, J., Rabener, E. M., Reiger, M., et al. (2015). Phage-mediated dispersal of biofilm and distribution of bacterial virulence genes is induced by quorum sensing. PLoS Pathog. 11:e1004653. doi: 10.1371/journal.ppat.1004653
126. Rumbaugh, K. P., and Ahmad, I. (eds) (2014). Antibiofilm Agents. Berlin: Springer. Available at: http://link.springer.com/10.1007/978-3-642-53833-9 [accessed September 25, 2015]
127. Sanders, J., Pithie, A., Ganly, P., Surgenor, L., Wilson, R., Merriman, E., et al. (2008). A prospective double-blind randomized trial comparing intraluminal ethanol with heparinized saline for the prevention of catheter-associated bloodstream infection in immunosuppressed haematology patients. J. Antimicrob. Chemother. 62, 809-815. doi: 10.1093/jac/dkn284
128. Saxena, A. K., Panhotra, B. R., and Naguib, M. (2002). Sudden irreversible sensory-neural hearing loss in a patient with diabetes receiving amikacin as an antibiotic-heparin lock. Pharmacotherapy 22, 105-108. doi: 10.1592/phco.22.1.105.33507
129. Scannapieco, F. A., Yu, J., Raghavendran, K., Vacanti, A., Owens, S. I., Wood, K., et al. (2009). A randomized trial of chlorhexidine gluconate on oral bacterial pathogens in mechanically ventilated patients. Crit. Care Lond. Engl. 13:R117. doi: 10.1186/cc7967
130. Scholtz, V., Pazlarova, J., Souskova, H., Khun, J., and Julak, J. (2015). Nonthermal plasma-A tool for decontamination and disinfection. Biotechnol. Adv. 33, 1108-1119. doi: 10.1016/j.biotechadv.2015.01.002
131. Sepehr, S., Rahmani-Badi, A., Babaie-Naiej, H., and Soudi, M. R. (2014). Unsaturated fatty acid, cis-2-decenoic acid, in combination with disinfectants or antibiotics removes pre-established biofilms formed by food-related bacteria. PLoS ONE 9:e101677. doi: 10.1371/journal.pone.0101677
132. Siala, W., Mingeot-Leclercq, M.-P., Tulkens, P. M., Hallin, M., Denis, O., and Van Bambeke, F. (2014). Comparison of the antibiotic activities of daptomycin, vancomycin, and the investigational fluoroquinolone delafloxacin against biofilms from Staphylococcus aureus clinical isolates. Antimicrob. Agents Chemother. 58, 6385-6397. doi: 10.1128/AAC.03482-14
133. Sibille, I., Sime-Ngando, T., Mathieu, L., and Block, J. C. (1998). Protozoan bacterivory and Escherichia coli survival in drinking water distribution systems. Appl. Environ. Microbiol. 64, 197-202
134. Singh, R., Ray, P., Das, A., and Sharma, M. (2010). Penetration of antibiotics through Staphylococcus aureus and Staphylococcus epidermidis biofilms. J. Antimicrob. Chemother. 65, 1955-1958. doi: 10.1093/jac/dkq257
135. Slobbe, L., Doorduijn, J. K., Lugtenburg, P. J., El Barzouhi, A., Boersma, E., van Leeuwen, W. B., et al. (2010). Prevention of catheter-related bacteremia with a daily ethanol lock in patients with tunnelled catheters: a randomized, bo-controlled trial. PLoS ONE 5:e10840. doi: 10.1371/journal.pone.0010840
136. Solomon, L. R., Cheesbrough, J. S., Ebah, L., Al-Sayed, T., Heap, M., Millband, N., et al. (2010). A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis. Am. J. Kidney Dis. Off. J. Natl. Kidney Found. 55, 1060-1068. doi: 10.1053/j.ajkd.2009.11.025
137. Souweine, B., Lautrette, A., Gruson, D., Canet, E., Klouche, K., Argaud, L., et al. (2015). Ethanol lock and risk of hemodialysis catheter infection in critically ill patients. A randomized controlled trial. Am. J. Respir. Crit. Care Med. 191, 1024-1032. doi: 10.1164/rccm.201408-1431OC
138. Stacy, A., McNally, L., Darch, S. E., Brown, S. P., and Whiteley, M. (2016). The biogeography of polymicrobial infection. Nat. Rev. Microbiol. 14, 93-105. doi: 10.1038/nrmicro.2015.8
139. Stewart, P. S., Davison, W. M., and Steenbergen, J. N. (2009). Daptomycin rapidly penetrates a Staphylococcus epidermidis biofilm. Antimicrob. Agents Chemother. 53, 3505-3507. doi: 10.1128/AAC.01728-08
140. Sugimoto, S., Iwamoto, T., Takada, K., Okuda, K.-I., Tajima, A., Iwase, T., et al. (2013). Staphylococcus epidermidis Esp degrades specific proteins associated with Staphylococcus aureus biofilm formation and host-pathogen interaction. J. Bacteriol. 195, 1645-1655. doi: 10.1128/JB.01672-12
141. Tang, H.-J., Chen, C.-C., Cheng, K.-C., Toh, H.-S., Su, B.-A., Chiang, S.-R., et al. (2012). In vitro efficacy of fosfomycin-containing regimens against methicillin-resistant Staphylococcus aureus in biofilms. J. Antimicrob. Chemother. 67, 944-950. doi: 10.1093/jac/dkr535
142. Tang, H.-J., Chen, C.-C., Cheng, K.-C., Wu, K.-Y., Lin, Y.-C., Zhang, C.-C., et al. (2013). In vitro efficacies and resistance profiles of rifampin-based combination regimens for biofilm-embedded methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 57, 5717-5720. doi: 10.1128/AAC.01236-13
143. Tattawasart, U., Maillard, J. Y., Furr, J. R., and Russell, A. D. (1999). Development of resistance to chlorhexidine diacetate and cetylpyridinium chloride in Pseudomonas stutzeri and changes in antibiotic susceptibility. J. Hosp. Infect. 42, 219-229. doi: 10.1053/jhin.1999.0591
144. Thurlow, L. R., Hanke, M. L., Fritz, T., Angle, A., Aldrich, A., Williams, S. H., et al. (2011). Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo. J. Immunol. 1950, 6585-6596. doi: 10.4049/jimmunol.1002794
145. Timsit, J.-F., Dubois, Y., Minet, C., Bonadona, A., Lugosi, M., Ara-Somohano, C., et al. (2011). New challenges in the diagnosis, management, and prevention of central venous catheter-related infections. Semin. Respir. Crit. Care Med. 32, 139-150. doi: 10.1055/s-0031-1275526
146. Trautner, B. W., and Darouiche, R. O. (2004). Catheter-associated infections: pathogenesis affects prevention. Arch. Intern. Med. 164, 842-850. doi: 10.1001/archinte.164.8.842
147. US Food and Drug Administration (2000). Warning on Tricitrasol Dialysis Catheter Anticoagulant FDATP 4, 2000. Available at: http://www.hdcn.com/00/004fdci.htm [accessed December 30, 2015]
148. Valle, J., Re, S., Henry, N., Fontaine, T., Balestrino, D., Latour-Lambert, P., et al. (2006). Broad-spectrum biofilm inhibition by a secreted bacterial polysaccharide. Proc. Natl. Acad. Sci. U.S.A. 103, 12558-12563. doi: 10.1073/pnas.0605399103
149. Villatte, G., Massard, C., Descamps, S., Sibaud, Y., Forestier, C., and Awitor, K.-O. (2015). Photoactive TiO2 antibacterial coating on surgical external fixation pins for clinical application. Int. J. Nanomed. 10, 3367-3375. doi: 10.2147/IJN.S81518
150. Vuotto, C., Longo, F., and Donelli, G. (2014). Probiotics to counteract biofilm-associated infections: promising and conflicting data. Int. J. Oral Sci. 6, 189-194. doi: 10.1038/ijos.2014.52
151. Walder, B., Pittet, D., and Tramèr, M. R. (2002). Prevention of bloodstream infections with central venous catheters treated with anti-infective agents depends on catheter type and insertion time: evidence from a meta-analysis. Infect. Control Hosp. Epidemiol. 23, 748-756. doi: 10.1086/502005
152. Walz, J. M., Avelar, R. L., Longtine, K. J., Carter, K. L., Mermel, L. A., Heard, S. O., et al. (2010). Anti-infective external coating of central venous catheters: a randomized, noninferiority trial comparing 5-fluorouracil with chlorhexidine/silver sulfadiazine in preventing catheter colonization. Crit. Care Med. 38, 2095-2102. doi: 10.1097/CCM.0b013e3181f265ba
153. Wang, H., Huang, T., Jing, J., Jin, J., Wang, P., Yang, M., et al. (2010a). Effectiveness of different central venous catheters for catheter-related infections: a network meta-analysis. J. Hosp. Infect. 76, 1-11. doi: 10.1016/j.jhin.2010.04.025
154. Wang, Q., Sun, F.-J., Liu, Y., Xiong, L.-R., Xie, L.-L., and Xia, P.-Y. (2010b). Enhancement of biofilm formation by subinhibitory concentrations of macrolides in icaADBC-positive and-negative clinical isolates of Staphylococcus epidermidis. Antimicrob. Agents Chemother. 54, 2707-2711. doi: 10.1128/AAC.01565-09
155. Willatts, S. M., Radford, S., and Leitermann, M. (1995). Effect of the antiendotoxic agent, taurolidine, in the treatment of sepsis syndrome: a bo-controlled, double-blind trial. Crit. Care Med. 23, 1033-1039. doi: 10.1097/00003246-199506000-00007
156. Wingender, J., and Flemming, H.-C. (2011). Biofilms in drinking water and their role as reservoir for pathogens. Int. J. Hyg. Environ. Health 214, 417-423. doi: 10.1016/j.ijheh.2011.05.009
157. Wrzosek, L., Miquel, S., Noordine, M.-L., Bouet, S., Joncquel Chevalier-Curt, M., Robert, V., et al. (2013). Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent. BMC Biol. 11:61. doi: 10.1186/1741-7007-11-61
158. Wu, C.-C., Lin, C.-T., Wu, C.-Y., Peng, W.-S., Lee, M.-J., and Tsai, Y.-C. (2015). Inhibitory effect of Lactobacillus salivarius on Streptococcus mutans biofilm formation. Mol. Oral Microbiol. 30, 16-26. doi: 10.1111/omi.12063
159. Xie, Z., Siddiqi, N., and Rubin, E. J. (2005). Differential antibiotic susceptibilities of starved Mycobacterium tuberculosis isolates. Antimicrob. Agents Chemother. 49, 4778-4780. doi: 10.1128/AAC.49.11.4778-4780.2005
160. Zacharioudakis, I. M., Zervou, F. N., Arvanitis, M., Ziakas, P. D., Mermel, L. A., and Mylonakis, E. (2014). Antimicrobial lock solutions as a method to prevent central line-associated bloodstream infections: a meta-analysis of randomized controlled trials. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 59, 1741-1749. doi: 10.1093/cid/ciu671
161. Zhang, Y.-C., Zhang, L.-W., Ma, W., Yi, H.-X., Yang, X., Du, M., et al. (2012). Screening of probiotic lactobacilli for inhibition of Shigella sonnei and the macromolecules involved in inhibition. Anaerobe 18, 498-503. doi: 10.1016/j.anaerobe.2012.08.007
162. Zhao, Y., Li, Z., Zhang, L., Yang, J., Yang, Y., Tang, Y., et al. (2014). Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials. Am. J. Kidney Dis. Off. J. Natl. Kidney Found. 63, 479-490. doi: 10.1053/j.ajkd.2013.08.016